Lataa...

Anti-RhoC siRNAs inhibit the proliferation and invasiveness of breast cancer cells via modulating the KAI1, MMP9, and CXCR4 expression

Overexpression of RhoC in breast cancer cells indicates poor prognosis. In the present study, we aim to investigate the possible antitumor effects of anti-RhoC small-interfering RNA (siRNA) in inflammatory breast cancer cells. In this study, a specific anti-RhoC siRNA was used to inhibit RhoC synthe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Onco Targets Ther
Päätekijät: Xu, Xu-Dong, Shen, Han-Bin, Zhu, Li, Lu, Jian-Qin, Zhang, Lin, Luo, Zhi-Yong, Wu, Ya-Qun
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2017
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5370064/
https://ncbi.nlm.nih.gov/pubmed/28367066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S93164
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!